REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements for the Year Ended 31 March 2021 |
|
for |
|
PharmaSEAL International Limited |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited Financial Statements for the Year Ended 31 March 2021 |
|
for |
|
PharmaSEAL International Limited |
PharmaSEAL International Limited (Registered number: 09993255) |
|
Contents of the Financial Statements |
for the Year Ended 31 March 2021 |
|
|
|
|
|
|
|
|
|
|
Page |
|
Company Information | 1 |
|
Balance Sheet | 2 |
|
Notes to the Financial Statements | 4 |
|
PharmaSEAL International Limited |
|
|
Company Information |
for the Year Ended 31 March 2021 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
Chartered Accountants |
83 Park Road |
Chilwell |
Nottingham |
NG9 4DE |
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Balance Sheet |
31 March 2021 |
|
31.3.21 | 31.3.20 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
|
|
|
CURRENT ASSETS |
Debtors | 5 |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 6 |
|
|
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CREDITORS |
Amounts falling due after more than one
year |
7 |
|
|
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
Called up share capital | 8 |
|
|
Share premium | 9 |
|
|
Retained earnings | 9 | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS |
|
|
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Balance Sheet - continued |
31 March 2021 |
|
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered. |
|
The financial statements were approved by the Board of Directors and authorised for issue on
|
|
|
|
|
|
|
|
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Notes to the Financial Statements |
for the Year Ended 31 March 2021 |
|
|
1. | STATUTORY INFORMATION |
|
PharmaSEAL International Limited is a
|
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
|
Tangible fixed assets |
|
Computer equipment | - |
|
|
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
|
Current or deferred taxation assets and liabilities are not discounted. |
|
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
|
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
|
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
|
Hire purchase and leasing commitments |
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
|
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
|
3. | EMPLOYEES AND DIRECTORS |
|
The average number of employees during the year was
|
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2021 |
|
|
4. | TANGIBLE FIXED ASSETS |
Plant and |
machinery |
etc |
£ |
COST |
At 1 April 2020 |
|
Additions |
|
At 31 March 2021 |
|
DEPRECIATION |
At 1 April 2020 |
|
Charge for year |
|
At 31 March 2021 |
|
NET BOOK VALUE |
At 31 March 2021 |
|
At 31 March 2020 |
|
|
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.21 | 31.3.20 |
£ | £ |
Trade debtors |
|
|
Other debtors |
|
|
Directors' current accounts | 1 | - |
Tax |
|
|
VAT |
|
|
|
|
|
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.21 | 31.3.20 |
£ | £ |
Bank loans and overdrafts |
|
|
Trade creditors |
|
|
Social security and other taxes |
|
|
Other creditors |
|
|
Directors' current accounts | - | 141,999 |
Deferred income |
|
|
Accrued expenses |
|
|
|
|
PharmaSEAL International Limited (Registered number: 09993255) |
|
|
Notes to the Financial Statements - continued |
for the Year Ended 31 March 2021 |
|
|
7. |
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR |
31.3.21 | 31.3.20 |
£ | £ |
Bank loans - 1-2 years |
|
|
Bank loans - 2-5 years |
|
|
|
|
|
8. | CALLED UP SHARE CAPITAL |
|
|
|
|
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31.3.21 | 31.3.20 |
value: | £ | £ |
|
Ordinary | £0.00001 | 1 | 1 |
|
A Ordinary | £0.00001 | 4 | 2 |
NIL | G Ordinary Shares | £0.00001 | - | - |
5 | 3 |
|
244,868 A Ordinary shares of nominal value £0.0001 were issued during the year. |
173,868 were issued at a premium of £2.9999 for cash. |
71,000 were issued at a a premium of £1.9999. These were issued in satisfaction of a loan owed by the company to the allottee. |
The G Ordinary Shares were cancelled. |
|
9. | RESERVES |
Retained | Share |
earnings | premium | Totals |
£ | £ | £ |
|
At 1 April 2020 | ( |
) |
|
17,076 |
Deficit for the year | ( |
) | ( |
) |
Cash share issue | - | 663,587 | 663,587 |
At 31 March 2021 | ( |
) |
|
319,858 |
|
10. | GOING CONCERN |
|
In common with other start-up companies, at the balance sheet date, liabilities exceeded assets and cash reserves. The director's are in discussion with prospective investors and firmly believe that they will be able to secure sufficient funds from a combination of trading activities, grants and existing and new investors to allow the company to meet its obligations as they fall due. Accordingly, the accounts have been prepared on a going concern basis. |